Approved by
Health and Disability Ethics Committees

Ethics Committee reference:
2024 FULL 20075

Ethics Committee reference:
2024 FULL 20075

BerriQi for post-respiratory infection recovery

A Clinical Study for Children

BerriQi, a natural whole fruit-based product developed by Anagenix Ltd, may support immune and lung health. We’re conducting a clinical study to investigate if BerriQi can help children recover faster from respiratory illnesses and reduce school absenteeism.

Participants

Children aged 5-13 years

Duration

14 days

Procedure

Participants will consume 2 delicious chewable tablets daily and complete a symptom questionnaire

What is BerriQi®?

BerriQi® is a freeze-dried powder made from New Zealand Boysenberries and apples. It contains natural bioactives, including anthocyanins, that may support the immune system during recovery from respiratory infections.

Whole fruit powderBoysenberry and Apple

Important Information

✓ Participation is voluntary, and you can withdraw at any time.

✓ All information will be kept confidential.

✓ The study has been approved by the Health and Disability Ethics Committee.

Participant Information Sheet

For detailed information on the study 

Join us

in exploring how BerriQi® can potentially improve children’s health and reduce school absences due to respiratory illnesses.

FAQ for parents

Anagenix is a leading manufacturer and supplier of wholefood nutraceuticals for functional food and health supplement brands in the world’s biggest markets. Our science-backed products are based on New Zealand-grown plant bioactives that are painstakingly protected by our fully-integrated solution for taking raw materials from orchard to supplement-ready ingredients. We have partnered with many of New Zealands key research organizations and universities (Plant and Food Research, Callaghan Innovation, The University of Auckland) to further our scientific understanding of New Zealand fruit based nutraceuticals.

BerriQi® is a freeze-dried powder made from boysenberries and apples.

Yes, BerriQi is safe as it is made from natural fruits—boysenberries and apples. It is not an extract and contains all the natural constituents of the fruit in their natural ratios. However, if your child has a berry or apple allergy, they should not consume it.

No, there are no known side effects unless your child is allergic to boysenberries or apples.

Not really, it is safe for all age group. However, to prevent any choking hazard we recommend not using the chewable below 5 years.

Your child should take two chewable tablets daily and complete a symptom questionnaire every day for 14 days.

No, all personal information collected will remain confidential. Any reports generated will not include information that identifies your child.

Yes, participants can withdraw from the study at any time.

Yes, the study has been approved by the Health and Disability Ethics Committees (HDEC).

No, the treatment is randomly assigned by a computer system. Your child may receive either the active product or a placebo, and neither you nor the researcher will know which one.

The placebo used in the trial is a blend of heat-treated boysenberries (no anthocyanin) and apple. So, despite the absence of anthocyanins the placebo still contains all of the constituents of boysenberries and apples.

Boysenberries contain specific anthocyanin that supports a type of immune cell to switch from fight mode (during an active infection) into clean-up mode and further into recovery mode. This process may aid in faster recovery after a respiratory infection. However, its effects in children have not yet been studied, and this research aims to explore that.

Yes, BerriQi can be given to children with existing respiratory condition (like asthma or cystic fibrosis) as it may help mitigate their symptoms. However, the study is not designed to evaluate the difference in symptoms between healthy or individuals with respiratory conditions.

BerriQi will come as chewable tablet.

Two chewable tablets to be taken orally each morning before or with breakfast.

Dr. Aahana Shrestha

Contact Information

For more information or to participate, please contact:

Dr. Aahana Shrestha, Clinical Study Manager
Phone: +64223038409
Email: aahana.shrestha@anagenix.com
             clinical@anagenix.com